TrialThe Journal of clinical investigation2022

Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas.

Hirokazu Ogino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.